Kymera Therapeutics
KYMR
KYMR
115 hedge funds and large institutions have $2.04B invested in Kymera Therapeutics in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 63 increasing their positions, 22 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
+5
Holders Change %
+4.55%
% of All Funds
2.02%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
21
Increased
63
Reduced
22
Closed
16
Calls
$13.1M
Puts
$549K
Net Calls
+$12.5M
Net Calls Change
+$5.12M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AGM
126
Alpine Global Management
New York
| – | -$298K | -6,144 | Closed |
|
|
VF
127
Virtu Financial
New York
| – | -$295K | -6,085 | Closed |
|
|
GT
128
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$242K | -5,000 | Closed |
|
129
Lazard Asset Management
New York
| – | -$73K | -1,512 | Closed |
|
|
PCM
130
Pinz Capital Management
New York
| – | -$19K | -400 | Closed |
|
|
S
131
SignatureFD
Atlanta,
Georgia
| – | -$1K | -16 | Closed |
|